Shanghai Haohai Biological Technology Co., Ltd. (06826) released a Next Day Disclosure Return, highlighting no changes in its total issued H shares. As of 12 November 2025, the number of issued H shares (excluding treasury shares) remained at 38,529,240.
Meanwhile, the company maintains 190,203,760 issued A shares and 3,848,095 treasury A shares, for a total of 194,051,855 A shares. No additional changes to A shares or treasury A shares were reported as of 12 November 2025.
The return also revealed multiple repurchase transactions associated with H shares that have yet to be canceled, covering buybacks made between 15 September 2025 and 12 November 2025. On 12 November 2025, 22,000 H shares were repurchased at a highest price of HKD 28.1 and a lowest price of HKD 27.96, with an aggregate price of HKD 617,844. The company’s board confirms that all repurchases complied with applicable listing rules and regulations.